Sun Spot Removal: IPL, Laser and Peels for Age Spots

Sun spot removal is the umbrella for the in-office treatments that fade or clear age spots — spots the American Academy of Dermatology (AAD) describes as appearing on sun-exposed areas such as the face and hands.

The devices below use the same spot's other names in their paperwork: lentigos, solar lentigos or, in treatment studies, lentigines.

Med spas draw on several device families for the job — intense pulsed light (IPL) and its branded versions, picosecond lasers and fractional resurfacing lasers — with cryosurgery, microdermabrasion and chemical peels as the non-light alternatives.

ASPS defines IPL as a minimally invasive, non-laser light treatment that emits multiple wavelengths; the skin absorbs the light and converts it to heat, and the targets are pigment, blood vessels and hair follicles. IPL photofacial — the name you will see on med spa menus — is a marketing name rather than a cleared indication, and the light is not laser light.

BBL, which you will see next to it on the same menus, is not a separate technology either: it is Sciton's own brand of IPL, and our BBL guide covers that platform in depth.

Lasers deliver a single wavelength instead of a broad flash.

The American Society for Dermatologic Surgery (ASDS) defines non-ablative laser treatment as creating heat without injuring the skin surface, and ablative resurfacing as removing layers of skin; fractionated handpieces deliver the beam as small dots, and Solta's own Fraxel recovery timeline lists visible laser dots on days 1–2.

The picosecond family — the devices behind the term pico laser — includes PicoSure, a 755 nm Alexandrite picosecond laser with optional 532 nm and 1064 nm delivery systems, 510(k)-cleared for tattoo and benign pigmented lesion removal.

Cleared is the operative word: PicoSure, PicoWay and PiQo4 are all Class II 510(k)-cleared "powered laser surgical instruments," not FDA-approved.

Two more families matter for sun spots.

Sciton's JOULE 1927 nm laser is 510(k)-cleared (K182173, 6 March 2019) for soft-tissue coagulation, actinic keratosis and benign pigmented lesions such as lentigos (age spots), solar lentigos (sun spots) and freckles — and Sciton markets Moxi as its fractionated non-ablative 1927 nm laser, though the clearance text names the wavelength, not the brand.

Solta's Fraxel FTX, cleared 21 August 2024 with 1550 nm and 1927 nm wavelengths, states indications that include age spots and sun spots on both wavelengths and melasma on the 1550 nm one.

The treat list, in the sources' own words: Sciton's 1927 nm clearance covers benign pigmented lesions such as lentigos, solar lentigos and freckles.

Solta's Fraxel indications include dyschromia, age spots and sun spots on the 1550 nm wavelength and pigmented lesions such as age spots, sun spots and freckles on the 1927 nm one.

PicoWay's 510(k) clears 532 nm and 1064 nm for melasma in Fitzpatrick skin types I–IV and its 532/730 nm wavelength for lentigines in the same types.

The AAD's options list for age spots adds cryosurgery, microdermabrasion and chemical peels to lasers.

Skin tone decides fit before anything else.

Sciton says BBL HEROic treats skin types I–V on the Fitzpatrick scale — not type VI — for pigment, with only its infrared SkinTyte mode described as usable on types V and VI.

PicoWay's lentigo clearance covers types I–IV, and PicoSure's 532 nm delivery system is cleared for types I–III only.

Those are manufacturers' and clearance statements; your own Fitzpatrick type, tanning history and how your skin has responded to injury or darkening before are consultation questions, not table lookups.

Melasma is the look-alike that changes the conversation.

The AAD describes it as a skin condition that causes patches and spots, usually on the face, that are darker than the person's natural skin tone, and it puts suspected melasma in the see-a-dermatologist-first category, because it may be another condition.

Its best-studied treatments are topical: a 2020 evidence-based review of 113 studies and 6,897 participants concluded that hydroquinone and triple-combination cream are the most effective, best-studied melasma treatments and that chemical peels and laser or light therapies are "equal or inferior to topicals," with a higher risk of adverse effects.

Because melasma can cause spots as well as patches, which one you have is a question for that dermatologist exam, not for a mirror; our melasma treatment guide covers how it is treated.

The honest answer comes first: this page prints no price, because there is no national average it can verify.

ASPS's 2025 procedural statistics release stopped reporting minimally invasive procedure counts and fees, so no current ASPS average fee exists for IPL or BBL, and this guide's research, completed in October 2026, found no tier-1 or tier-2 national figure for IPL photofacials, BBL or Fraxel.

A price presented as the national average for sun spot removal deserves the question "says who?"

The nearest sourced number belongs to a related but different procedure: ASPS's laser skin resurfacing cost page gives an average of $1,829 per its latest statistics — a physician fee only, with the year not stated, covering resurfacing procedures generally rather than spot treatment, and it is not a med spa price.

What a quote is made of: how practices price a course — per session, as a package or by area — is not something this research established for the devices on this page, so the session count is the multiplier to ask about.

The makers' own session expectations differ — Solta says up to five Fraxel treatments may be appropriate, while Sciton recommends 2–4 Moxi treatments — and Sciton ties a BBL session's length to the size and condition of the area being treated, which is one more reason to compare quotes for the same area.

One coverage point is explicit in the sources: the AAD says insurance does not cover chemical peels.

For age spots specifically, the AAD's benchmark is short: one or two laser treatments can treat age spots quickly, with longer-lasting results than a fading cream.

Device-level expectations run longer: Solta says Fraxel results may show after one treatment but that "up to five treatments may be appropriate," and Sciton recommends 2–4 Moxi treatments.

The category evidence is a 2025 systematic review of solar lentigines treatment — 41 trials, 3,234 patients — reporting success ranges of 74.6–90% for IPL, 67.9–93.02% for picosecond laser, 36.36–76.6% for Q-switched laser and 37–71.4% for cryotherapy.

Read the ranges with their limits: they pool different trials, patients and success measures rather than head-to-head comparisons, so they are not a ranking, and a study-level range is not a prediction for any one person.

How long results last is the question with the weakest sourcing.

The only IPL follow-up this research found is 4 to 6 months, in one photorejuvenation study that measured wrinkles and elastosis rather than spots, and it found no sourced multi-year figure for IPL — so a "permanent" or "lasts for years" promise deserves the question "says who?" The AAD's durability point is the practical one: age spots can return without sun protection, and Solta advises SPF 30+ and avoiding direct sun for at least 3 months after a final Fraxel treatment.

Comfort and recovery depend on the device and its settings, and the sourced picture is thin.

Solta says a full-face Fraxel treatment takes 20–25 minutes after about 60 minutes of topical numbing, and its recovery timeline runs: a sunburn feeling for 1–3 hours, then itching, flaking and visible laser dots or darkening on days 1–2, facial peeling usually on days 3–4, and redness resolved by about day 15 in its example patient.

That is one published example, not a timeline every face follows.

Sciton's statements are lighter: a Moxi treatment takes 8–10 minutes, with recovery the company describes as little to none, and a Forever Young BBL session — its protocol aimed at aging and sun damage — runs about 30 minutes with skin feeling warm for 30–60 minutes afterward and downtime typically minimal.

Those are the maker's words; "minimal downtime" is a marketing phrase until your own skin proves it.

Two sourced expectations bridge the gap.

The AAD says lasers can cause crusting or temporary darkening after age spot treatment, and Solta's own timeline has treated skin darkening before it peels — so looking worse for a few days is part of the described course, not a surprise.

For IPL discomfort specifically, no pain measurement came out of this research; what a session feels like is a direct question for the practice you are considering.

No overall complication rate for sun spot removal came out of this research, so the sourced lists are the map.

For age spots, the AAD says lasers can cause crusting or temporary darkening, and that cryosurgery — freezing — can leave permanent darkening, lightening or scarring, though it calls that rare when a dermatologist performs it.

In the solar lentigines review, IPL and pulsed dye were the modalities less associated with post-inflammatory hyperpigmentation — new darkening after inflammation — while cryotherapy came with more severe side effects.

Resurfacing lasers carry the longest list, and it belongs to the maker.

Solta lists Fraxel adverse events including blistering and burns, temporary or permanent skin color change, eye injury, infection, keloids, prolonged redness, scarring and bruising, with listed contraindications including keloid tendency, systemic steroids and isotretinoin; Fraxel is prescription-only.

The cleared-versus-approved distinction matters here too: these devices are 510(k)-cleared, and a clearance is not a statement that complications cannot happen.

The broadest comparison in this research is a 2023 systematic review of lentigo treatment — 48 articles, 1,763 patients — which counted complete responses by modality family: 65% for combination treatments, 43% for laser-based treatments, 21% for topical retinoids, 15% for cryotherapy and 6% for peels, concluding that cryotherapy's response rates are "substantially lower" than previously assumed.

It measured different outcomes from the 2025 review above, so the two sets of numbers cannot be merged or ranked against each other.

Creams are the alternative the AAD's own comparison sets against lasers.

The AAD's comparison favors procedures on speed and durability — one or two laser treatments, longer-lasting than a fading cream — and on the prescription side, hydroquinone is not legally sold over the counter: since the CARES Act took effect on 23 September 2020 there have been no FDA-approved or legally marketed over-the-counter hydroquinone skin lighteners in the US, the FDA warned 12 companies in April 2022, and it names Tri-Luma — prescription-only — as the only FDA-approved drug containing hydroquinone.

Chemical peels sit lower in the lentigo review's numbers (6% complete response) but are an option the AAD lists for sun-damaged skin, age spots, freckles and uneven tone.

Two cautions travel with them: peels are cosmetic and insurance does not cover them, and the FDA advises using a chemical peel only under the supervision of a licensed, trained provider because some at-home peels caused serious injuries.

Our chemical peels guide covers types, cost and recovery.

Microdermabrasion is the last entry on the AAD's list: Cleveland Clinic says it can make age spots less noticeable, with bruising, discoloration, flaking and sun sensitivity as downsides, and it says most people need multiple treatments; the AAD's summary cites about 40% clearance of spots in one 16-week study, better when combined with a peel.

Which option suits a particular spot is a clinical judgment — the spot's nature, your skin type and tone, your pigment history and the recovery you can take — and it belongs to a licensed provider after an examination, not to a comparison table.

Start with the legal layer, because who may do what in a med spa is set by state law.

AmSpa — the American Med Spa Association — says injecting botulinum toxin is the practice of medicine because it is a prescription drug affecting living tissue, so it must be done by a physician, an independent-practice NP or another licensed professional acting within their scope, under rules that vary by state.

A practice considering you for a laser or light treatment should be able to say specifically who will operate the device, what license that person holds, and under whose supervision — our med spa laws by state guide covers who can inject and who must supervise.

The medical layer is checkable here.

The AAD recommends a board-certified dermatologist skin exam before age spots are treated, so a fair question is whether the practice examines spots itself or refers first.

Solta describes Fraxel as prescription-only, and the FDA's advice on peels — licensed, trained supervision only — shows the pattern: these are medical-setting treatments, whatever the storefront looks like.

Before-and-after photos deserve skepticism aimed at the right things.

Under the FTC's Endorsement Guides (16 CFR 255.2), a result shown in an ad is read as representative of what consumers generally achieve; if it is not, the ad must clearly disclose generally expected results, and the FTC says disclaimers like "results not typical" are generally insufficient on their own.

In any gallery, check the treatment count, the time since treatment, the lighting and whether the photos are unretouched.

Treat "near me" as the last filter, not the first: a nearby practice that cannot answer the questions above is not the nearest good option.

Our how to choose a med spa checklist covers credentials, red flags and verification steps in depth.